14-77027787-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_024496.4(IRF2BPL):āc.6G>Cā(p.Ser2=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,572,376 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00093 ( 0 hom., cov: 32)
Exomes š: 0.0010 ( 2 hom. )
Consequence
IRF2BPL
NM_024496.4 synonymous
NM_024496.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.289
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 14-77027787-C-G is Benign according to our data. Variant chr14-77027787-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2644424.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr14-77027787-C-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.289 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000932 (142/152280) while in subpopulation AMR AF= 0.00412 (63/15304). AF 95% confidence interval is 0.0033. There are 0 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 142 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF2BPL | NM_024496.4 | c.6G>C | p.Ser2= | synonymous_variant | 1/1 | ENST00000238647.5 | NP_078772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BPL | ENST00000238647.5 | c.6G>C | p.Ser2= | synonymous_variant | 1/1 | NM_024496.4 | ENSP00000238647 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000933 AC: 142AN: 152162Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
142
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000850 AC: 178AN: 209368Hom.: 1 AF XY: 0.000857 AC XY: 99AN XY: 115544
GnomAD3 exomes
AF:
AC:
178
AN:
209368
Hom.:
AF XY:
AC XY:
99
AN XY:
115544
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00104 AC: 1472AN: 1420096Hom.: 2 Cov.: 34 AF XY: 0.000993 AC XY: 701AN XY: 705612
GnomAD4 exome
AF:
AC:
1472
AN:
1420096
Hom.:
Cov.:
34
AF XY:
AC XY:
701
AN XY:
705612
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000932 AC: 142AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000886 AC XY: 66AN XY: 74452
GnomAD4 genome
AF:
AC:
142
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
66
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | IRF2BPL: BP4, BP7 - |
IRF2BPL-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 26, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at